|Alert: Federal Drug Testing Custody and Control Form (CCF) Revisions Proposed
Department of Health and Human Services
Proposed Project: Mandatory Guidelines for Federal Workplace Drug Testing Programs (OMB No. 0930-0188) Revision
The Substance Abuse and Mental Health Services Administration (SAMHSA) published a Federal Register Notice on Agency Information Collection on February 11, 2020. The Notice reviews SAMHSA’s proposed revisions to the Federal Drug Testing Custody and Control Form (CCF) for the federal agency and federally regulated drug testing programs which must comply with the HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs for Urine (UrMG) and Oral Fluid (OFMG).
The Notice states:
The CCF is used by all federal agencies and employers regulated by the Department of Transportation (DOT) and the Nuclear Regulatory Commission (NRC) to document the collection and chain of custody of urine specimens at the collection site, for HHS-certified test facilities to report results, and for Medical Review Officers (MROs) to document and report a verified result. SAMHSA allows the use of the CCF as a paper or electronic form.
The current OMB-approved CCF has an August 31, 2020 expiration date. SAMHSA has resubmitted the CCF with major content revisions to the form for OMB approval. The content revisions are outlined in the Notice. However, an actual copy of the form with the proposed revisions was not included in the Notice.
Public Comment is invited on:
(a) Whether the proposed collections of information are necessary for the proper performance of the functions of the agency, including whether the information shall have practical utility;
(b) the accuracy of the agency
(c) ways to enhance the quality, utility, and clarity of the information to be collected; and
(d) ways to minimize the burden of the collection of information on respondents, including through the use of automated collection techniques or other forms of information technology.
The public comment period ends on April 13, 2020.